{"id":103085,"date":"2024-11-13T07:57:00","date_gmt":"2024-11-13T10:57:00","guid":{"rendered":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/eaaci-to-launch-world-anaphylaxis-awareness-day-on-21-november-at-faam-eurobat-2024\/"},"modified":"2024-11-13T07:57:00","modified_gmt":"2024-11-13T10:57:00","slug":"eaaci-to-launch-world-anaphylaxis-awareness-day-on-21-november-at-faam-eurobat-2024","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/releases\/releases-geral\/eaaci-to-launch-world-anaphylaxis-awareness-day-on-21-november-at-faam-eurobat-2024\/","title":{"rendered":"EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024"},"content":{"rendered":"

European Academy of Allergy and Clinical Immunology<\/b><\/p>\n

\"email<\/p>\n

ATHENS, Greece, Nov. 13, 2024 (GLOBE NEWSWIRE) — The European Academy of Allergy and Clinical Immunology (EAACI) is proud to announce the inaugural\u00a0World Anaphylaxis Awareness Day<\/strong> on\u00a021 November 2024<\/strong>. This landmark initiative, held on the opening day of\u00a0FAAM-EUROBAT 2024<\/strong>\u00a0in Athens, Greece, seeks to raise awareness and promote essential steps in preventing and managing anaphylaxis, a severe, potentially life-threatening allergic reaction.<\/p>\n

Anaphylaxis affects approximately 1-2% of the global population, with incidents on the rise worldwide. This severe allergic reaction demands immediate medical intervention and often stems from exposure to common allergens, including specific foods, insect stings, medications, or latex. Despite the risks, awareness of anaphylaxis symptoms, causes, and emergency responses remains low.\u00a0World Anaphylaxis Awareness Day<\/strong>\u00a0addresses these knowledge gaps and fosters a global understanding of this critical health issue.\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/p>\n

Through various educational activities, World Anaphylaxis Awareness Day will underscore the importance of prompt emergency responses and preventive measures. EAACI invites medical professionals, allergy societies, and stakeholders worldwide to participate and amplify the message within their communities.<\/p>\n

In conjunction with this day, EAACI will also release\u00a0A Practical Guide for Patients,<\/strong>\u00a0a comprehensive resource developed to support patients and caregivers in understanding, managing, and preventing anaphylactic reactions. This guide offers practical insights on identifying triggers, using adrenaline auto-injectors correctly, and creating personalised action plans to manage risk in everyday life.<\/p>\n

We are thrilled to launch World Anaphylaxis Awareness Day as part of FAAM-EUROBAT 2024, said Dr Maria Torres, EAACI President. With this initiative, we hope to empower individuals, families, and healthcare providers with the knowledge and tools to prevent and respond to anaphylaxis. This is an essential step toward improving patient care and reducing the impact of this serious health condition.<\/p>\n

FAAM-EUROBAT 2024<\/strong>, EAACIs renowned Food Allergy and Anaphylaxis Meeting, will run from 21-23 November, featuring global leaders in allergy research and care. World Anaphylaxis Awareness Day will serve as a key moment within the conference to highlight EAACIs commitment to patient safety and allergy awareness.<\/p>\n

For more information on World Anaphylaxis Awareness Day or the Practical Guide for Patients, please visit EAACI Anaphylaxis Awareness Day website<\/a>.<\/p>\n

https:\/\/eaaci.org\/events_meetings\/faam-2024\/<\/a><\/p>\n

https:\/\/eaaci.org\/about-eaaci\/<\/a><\/p>\n

Media Contact:<\/p>\n

maria.cubel@eaaci.org
<\/a>+ 41 44 205 55 39<\/p>\n

\"Linkedin<\/p>\n

Photos accompanying this announcement are available at:
https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/c27c467a-b7bf-4bfa-8f57-3cd3111da23b<\/a>
<\/a>https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/99c39d50-e140-468f-adbd-7255c9850f7b<\/a><\/p>\n



\n\"Primary<\/a><\/p>\n

\n
\n
\n
\n
EAACI ANAPHYLAXIS AWARENESS DAY<\/h5>\n<\/div>\n
<\/a><\/div>\n

\n

\n
Know the signs, take action: EAACI Anaphylaxis Awareness Day, 21 November<\/h5>\n<\/div>\n
\n
FAAM-EUROBAT 2024<\/h5>\n<\/div>\n
<\/a><\/div>\n

\n

\n
Food Allergy and Anaphylaxis Meeting & European Consortium on Application of Flow Cytometry in Allergy, Athens- Greece, 21-23 November<\/h5>\n<\/div>\n<\/div>\n<\/div>\n

A OESP<\/b> nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP<\/b> e sao de inteira responsabilidade da GlobeNewswire<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"ATHENS, Greece, Nov. 13, 2024 (GLOBE NEWSWIRE) — The European Academy of Allergy and Clinical Immunology (EAACI) is proud to announce the inaugural\u00a0World Anaphyla","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[34],"tags":[],"class_list":["post-103085","post","type-post","status-publish","format-standard","hentry","category-releases-geral"],"acf":[],"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/103085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=103085"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/103085\/revisions"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=103085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=103085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=103085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}